← SynDRA
DMH1
SynDRA canonical compound SYN0062852 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ACVR1 |
| Mechanism of action | ALK inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- DMH-1
- DMH 1
- 4-[6-(4-propan-2-yloxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
- 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline
- C24H20N4O
- CHEBI:86289
- 4-(6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin- 3-yl)quinoline
- 4-(6-{4-[(propan-2-yl)oxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)quinoline
- BMP Inhibitor II
- CHEMBL2385597
- SCHEMBL14671947
- BDBM36354
- DTXSID60679195
- HMS3653K11
- BCP09856
- EX-A2049
- HB3110
- MFCD18384963
- s7146
- ZINC62260292
- DMH1, >=98% (HPLC)
- AKOS024457987
- quinoline, 4-[6-[4-(1-methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-
- CCG-268407
- CS-3210
- SB19483
- NCGC00371039-08
- AC-31412
- AS-16458
- BD162772
- DA-34786
- HY-12273
- D5737
- FT-0755960
- SW220065-1
- C71710
- J-004378
- Q27159056
- 4-[6-[4-(1-Methylethoxy)phenyl]pyra zolo[1,5-a]pyrimidin-3-yl]-quinoline
Look up DMH1 in the interactive SynDRA portal →